ENDOMETRIAL CANCER

This study is testing a specialized type of radiation therapy called proton beam radiation for women who have had surgery for cervical or uterine cancer. The main goal is to see how often this treatment causes serious stomach and bowel side effects. Researchers will also track wh…

This study is testing whether the oral drug belzutifan can help control recurrent clear cell cancers of the ovary, uterus, cervix, and other gynecologic sites. It will enroll 32 adults who have already received platinum-based chemotherapy. Researchers will measure how well the dr…

This early-stage study is testing a new drug called IDE161, both alone and combined with an existing immunotherapy (pembrolizumab), for people with advanced solid tumors that have spread. The main goals are to find safe doses and see if the treatment shows early signs of shrinkin…

This early-stage study is testing a new drug, zanzalintinib, combined with a standard chemotherapy (paclitaxel) for people with recurrent high-grade uterine or endometrial cancer that has worsened after prior treatment. The main goal is to find the safest and most effective dose …

This study is testing a less invasive weight loss procedure for obese women who have completed curative treatment for endometrial cancer. Researchers want to see if an endoscopic stomach-suturing technique, combined with lifestyle changes, is a safe and feasible way to help these…

This early-phase study is testing whether a combination of chemotherapy, radiation therapy, and an immunotherapy drug called dostarlimab can help control stage IIIC endometrial cancer that has spread to lymph nodes. Researchers will primarily check if this three-part treatment is…

This early-stage study aims to find a safe and effective dose of a new drug called EIK1005 for people with advanced solid tumors that have spread or cannot be removed by surgery. Researchers will test EIK1005 by itself and combined with an existing immunotherapy drug (pembrolizum…

This study is testing whether doctors can safely use less intensive follow-up treatments for early-stage endometrial cancer based on the genetic makeup of each patient's tumor. The research involves 393 women who have already had surgery to remove their cancer. The goal is to see…

This early-stage study is testing whether an experimental drug called NRM-823 is safe and can help control advanced cancers that have stopped responding to standard treatments. Researchers will give NRM-823 alone and combined with immunotherapy to about 150 adults with various so…

This study is testing whether two drugs, abemaciclib and letrozole, can help control advanced or recurrent endometrial cancer after initial chemotherapy. The drugs are taken daily as maintenance therapy for up to two years to try to delay cancer progression. The trial will enroll…

This is an early-stage study testing a new drug called MT-4561 in people with various advanced solid tumors who have run out of standard treatment options. The main goals are to find a safe dose, see how the body processes the drug, and check for any early signs that it might hel…

This study is testing a new oral drug called ETX-19477 in adults with advanced solid tumors that have stopped responding to standard treatments. The main goals are to find a safe dose and see if the drug can help control the cancer. Researchers are especially interested in enroll…

This study is testing if adding a new targeted drug, sacituzumab tirumotecan, to an existing immunotherapy (pembrolizumab) works better than the immunotherapy alone to control advanced endometrial cancer. It is for over 1,100 people whose cancer has spread or returned after surge…

This is a very early-stage study to test the safety of a new drug called GV20-0251 in adults with advanced solid tumors that have progressed despite standard treatments. The main goal is to find a safe dose by giving the drug to small groups of patients at different levels. It is…

This study is testing whether a new three-drug combination, called PIKTOR plus paclitaxel, can help control advanced or returning endometrial cancer. It will also test if adding a special diet designed to lower insulin levels makes the treatment work better. The trial is for peop…

This is the first study in people testing a new cancer drug called MGC026. It aims to find a safe dose and see if the drug can help shrink tumors in adults with advanced solid tumors that have not responded to other treatments. The study will also check how the drug moves through…

This is an early-stage study testing a new oral drug called BG-68501 in people with advanced solid tumors that have spread or cannot be removed by surgery. The main goals are to find a safe dose and see how the body processes the drug, both when given alone and when combined with…

This early-stage trial is testing a new drug called AZD8205, both by itself and combined with other cancer drugs, for people with advanced solid tumors that have spread or returned. The main goals are to find safe doses and see if the treatments can shrink tumors. It is enrolling…

This study is testing a new oral drug, PC14586 (rezatapopt), for people with advanced solid tumors that have a specific mutation in a gene called TP53 (Y220C). The main goals are to find a safe and effective dose and to see if the drug can shrink tumors. The trial is enrolling up…

This is the first human study of LNCB74, a new targeted cancer drug designed to deliver chemotherapy directly to cancer cells. Researchers will test different doses in 145 adults with advanced solid tumors (including ovarian, breast, lung, and other cancers) to find the safest an…

This study is testing a new, more advanced robotic surgery system for treating early-stage endometrial (uterine) cancer. The goal is to perform the necessary cancer staging surgery through just one small abdominal incision instead of several. Researchers will enroll about 564 pat…

This is a very early, first-in-human study to test the safety and find the right dose of a new radioactive drug called 177Lu-RAD204. It is for adults with advanced solid tumors (like lung, breast, or skin cancer) that have spread and have stopped responding to standard treatments…

This study is testing whether combining two drugs, nab-sirolimus (given by IV) and letrozole (a daily pill), can help control advanced or recurrent endometrial cancer. It is for patients whose cancer has returned or spread and who have had zero to one prior rounds of chemotherapy…

This study is testing a personalized cell therapy called lifileucel for women with advanced endometrial cancer that has stopped responding to standard treatments like chemotherapy and immunotherapy. Doctors will collect a patient's own tumor-fighting immune cells, grow large numb…

This study compares new targeted drug combinations against standard chemotherapy for advanced or returning endometrial cancer. It will enroll 600 adults with specific tumor characteristics to see which approach better controls cancer growth and extends survival. Researchers are t…

This is the first human study of a new experimental cancer drug called HWK-007. Researchers are testing it in adults with advanced ovarian, endometrial, or non-small cell lung cancers that have stopped responding to standard treatments. The main goals are to find the safest dose …

This is a first-in-human study to test the safety and early signs of effectiveness of a new drug called STRO-004 in adults with advanced solid tumors that have come back or stopped responding to other treatments. The trial will test STRO-004 alone and in combination with an exist…

This early-stage trial is testing a new radioactive drug called 177LuBetaBart in adults with advanced solid cancers that have stopped responding to standard treatments. The study aims to find a safe dose and see if the drug shows early signs of fighting tumors. Participants will …

This study is testing a new oral drug called ART0380 in people with advanced or metastatic solid tumors that have spread and are hard to treat. The main goals are to find the safest and most effective dose of ART0380 when given alone or combined with standard chemotherapy drugs, …

This study aims to collect real-world information on how well a specific combination of cancer drugs works for women with advanced or recurrent endometrial (uterine) cancer in Germany. It will follow 150 patients who are already receiving this standard treatment in their regular …

This study aims to monitor the safety and real-world effectiveness of two approved cancer drugs, durvalumab and olaparib, in patients with endometrial cancer in Korea. It will follow about 50 patients for up to a year after they start treatment as part of their normal medical car…

This early-stage study is testing a new treatment called KD01, which is a specially engineered virus designed to infect and kill cancer cells. It is being given as a direct injection to women with cervical or endometrial cancer who have not responded to other treatments. The main…

This early-stage study is testing a new type of personalized cell therapy for adults with advanced solid tumors that have a specific genetic change called KRAS G12D. Doctors take a patient's own immune cells (T cells), genetically modify them in a lab to recognize and attack canc…

This study is testing whether a drug called elacestrant works better alone or combined with abemaciclib for people with advanced or returning endometrial cancer that has estrogen receptors. The trial will enroll 75 participants who have already received platinum-based chemotherap…

This early study is testing whether weight loss medications tirzepatide and semaglutide are practical and safe for endometrial cancer patients who are overweight or have diabetes and are undergoing chemotherapy. Researchers will enroll 36 patients to see if they can complete the …

This is the first study in humans to test the safety and find the right dose of a new drug called XmAb541 for people with advanced solid tumors, including ovarian, endometrial, and germ cell cancers. The main goal is to see how well the drug is tolerated and to check for side eff…

This is the first-ever study in people of a new targeted cancer drug called HWK-016. It aims to find a safe and effective dose for adults with advanced ovarian or endometrial cancer that has spread or come back. The study will test the drug alone and in combination with another c…

This study is testing a new combination of drugs (BL-B01D1, pembrolizumab, and sometimes bevacizumab) for women with advanced cervical or endometrial cancer that has returned or spread. The goal is to see if this combination can shrink tumors and control the disease better than c…

This study is testing whether a pre-surgery support program helps women with ovarian or endometrial cancer recover better. The program includes exercise, nutritional advice, and psychological support before their operation. Researchers will compare patients who receive this extra…

This study is testing a shorter, 3-week course of pelvic radiation for women with non-metastatic uterine or cervical cancer who have had surgery. The main goal is to find out if this shorter schedule is safe and tolerable, and to see how it affects patients' quality of life, bowe…

This early-stage trial is testing a new oral drug called ALTA2618 for people with advanced cancers that have a specific genetic mutation called AKT1 E17K. The study aims to find the safest and most effective dose and see how well the drug works against cancers like breast and end…

This is the first human study testing a new drug called IPH5301 for people with advanced cancers that have spread. The trial has two parts: first finding the safest dose of IPH5301 alone, then testing it combined with standard chemotherapy in breast cancer patients. It's for adul…

This study is testing whether matching drug combinations to a patient's specific tumor genetics can better control recurrent endometrial cancer. It will enroll about 148 women whose cancer has returned after initial treatment. Doctors will analyze each tumor's genetic profile and…

This study is testing whether a new drug called Rina-S works better than standard chemotherapy options for women whose endometrial cancer has returned or worsened after prior treatment. About 544 participants will be randomly assigned to receive either Rina-S or one of two standa…

This early-stage trial is testing a new immune therapy drug called ADU-1805, both alone and combined with an existing cancer drug (pembrolizumab). It aims to find safe doses and see if the treatment helps control advanced solid tumors that haven't responded to standard treatments…

This study is testing if taking a targeted pill called olaparib for one year after finishing standard chemo and radiation can help prevent a specific, aggressive type of endometrial cancer from returning. It will compare the pill to just watching closely (observation) in over 550…

This study is evaluating the safety and performance of the Medtronic Hugo robotic surgery system when used to perform hysterectomies. It will enroll about 70 adult women who need this surgery for various conditions, including fibroids, endometriosis, and certain cancers. The main…

This is the first study in people to test a new oral pill called NKT5097 for adults with advanced or metastatic solid tumors, with a focus on certain breast, ovarian, and uterine cancers. The main goals are to find a safe dose and understand the side effects. Researchers will als…

This study is testing whether a newer, targeted drug called trastuzumab deruxtecan (T-DXd) works better than standard chemotherapy after surgery for certain types of endometrial cancer. It is for people whose cancer tests positive for a protein called HER2. The main goal is to se…

This study is testing whether a much shorter, one-week course of targeted pelvic radiation, given alongside standard chemotherapy drugs, is practical for patients to complete. It aims to see if this combined approach is manageable for people with stage III endometrial cancer who …

This study is testing a new experimental drug, REGN5668, alone and in several combinations with other cancer drugs, for people with advanced ovarian, fallopian tube, peritoneal, or uterine cancers that have progressed after standard treatments. The main goals are to find the safe…

This study is testing new, personalized treatment plans for young women with early-stage endometrial (uterine) cancer who want to preserve their ability to have children. Instead of standard surgery, which removes the uterus, doctors will assign treatments based on the unique gen…

This program provides the investigational drug selinexor to patients with certain cancers who have run out of standard treatment options and don't qualify for ongoing clinical trials. It allows doctors to request the drug for eligible patients before it receives full regulatory a…

This study is testing whether a simple blood test can help doctors and patients decide when it might be safe to stop long-term immunotherapy for advanced or recurrent endometrial cancer. After one year of standard chemotherapy and immunotherapy, patients with a negative blood tes…

This study is testing an experimental drug called zanidatamab for people with advanced cancers that have a specific marker called HER2 and have stopped responding to prior treatments. It will enroll about 200 adults with various cancers including breast, lung, stomach, and ovaria…

This study is testing an experimental immunotherapy drug called lorigerlimab for women with advanced ovarian and other gynecologic cancers that have stopped responding to standard platinum-based chemotherapy. About 60 participants will receive the drug through an IV every three w…

This is the first study in people for a new oral medication called AVZO-021. It aims to find a safe dose and see if the drug can help control advanced solid tumors, including certain types of breast and ovarian cancer, when other standard treatments are no longer working. The stu…

This is a first-in-human study to test the safety and find the right dose of a new drug called PF-08046054/SGN-PDL1V for people with advanced solid tumors. It will be tested alone and in combination with another cancer drug, pembrolizumab. The study is recruiting 714 participants…

This study is testing a new, experimental cancer drug called AZD5335 to see if it is safe and if it can help control advanced cancers. It will be given alone and in combination with other cancer drugs to adults with ovarian, lung, or endometrial cancers that have progressed despi…

This is the first study in people to test a new drug called BL-B01D1. It aims to find a safe dose and see if it can help control advanced cancers that have spread or cannot be removed by surgery. The trial will enroll about 470 adults with various solid tumors, including lung, br…

This study is testing if adding an immunotherapy drug called Dostarlimab to standard radiation treatment can help prevent cancer from coming back in women with a specific, harder-to-treat type of advanced endometrial (uterine) cancer. It is for women who have already had surgery …

This early-stage trial is testing a new drug called CTIM-76 for people with advanced ovarian, testicular, or endometrial cancers that have stopped responding to standard treatments. The study will enroll 80 participants to determine safe dosage levels and see if the drug helps co…

This early-stage study is testing the safety of combining two drugs, atezolizumab and ONC201, for women with advanced or returning endometrial cancer that has spread. The trial will enroll 58 participants, including both obese and non-obese patients, to find the best dose for fut…

This study is testing a new drug called BNT323 for women whose endometrial (uterine) cancer has returned after previous treatments, including immunotherapy. It will compare BNT323 against standard chemotherapy to see which is better at controlling the cancer and helping patients …

This is the first study testing the experimental drug TORL-1-23 in people. Researchers aim to find a safe and effective dose for patients with advanced solid tumors, including ovarian, endometrial, and lung cancers. The study will enroll 90 participants to monitor side effects an…

This study tests whether a digital wellness platform with professional guidance can help endometrial cancer survivors adopt healthier lifestyles. Researchers will measure changes in waist size, body composition, and heart health markers over 24 weeks. The program focuses on nutri…

This study is testing a four-part treatment for advanced endometrial cancer that has come back or worsened after prior therapy. It combines a personalized vaccine made from a patient's own blood cells with three drugs designed to help the immune system attack the cancer. The goal…

This is the first human study of an experimental drug called SLV-154 for people with advanced solid tumors that have spread. The main goal is to find the highest safe dose and understand how the body processes the drug. About 70 adults with one of ten specific advanced cancers wh…

This is the first study in people to test a new drug called XMT-1660 for several types of advanced solid tumors that have returned or spread. The main goals are to find a safe dose and see what side effects it causes. Researchers will also look for early signs that the drug can s…

This study aims to determine the best surgical approach for evaluating lymph nodes during endometrial cancer surgery. Researchers will compare two methods—selective surgical staging versus reflex lymphadenectomy—in 625 women with early-stage endometrial cancer. The goal is to see…

This is the first study in people to test a new cancer drug called KIVU-107. The main goal is to find a safe dose and see how well the body handles it. It is for adults with advanced solid tumors that have spread or cannot be removed by surgery and have stopped responding to avai…

This is the first human study testing a new oral drug called MOMA-341 for people with advanced solid tumors that have specific genetic features (MSI-H or dMMR). The main goal is to find safe doses and see how the body handles the drug when taken alone or combined with other cance…

This study is testing whether adding an experimental drug called relacorilant to standard chemotherapy helps control advanced gynecologic cancers. It will enroll about 270 patients with ovarian, fallopian tube, peritoneal, or endometrial cancer that has returned or spread. The ma…

This early-stage study is testing a new drug called BL-M07D1 for people with advanced cancers that have a specific marker called HER2. The trial aims to find the safest dose and see if the drug helps control cancer growth in patients who have already tried standard treatments. Re…

This study is testing an experimental drug called patritumab deruxtecan (HER3-DXd) in people with advanced solid tumors that have spread or cannot be removed by surgery. The goal is to see if the drug can shrink tumors and control the disease in people who have already tried at l…

This study is testing a new drug called TER-2013 in people with advanced solid tumors that have specific genetic changes. The main goals are to find a safe dose and see if the drug can shrink tumors. It is for patients who have run out of standard treatment options.

This study is testing a new drug, TCC1727, combined with other cancer medications for people with advanced solid tumors that have stopped responding to standard treatments. The first part of the study aims to find the safest and most effective dose. The second part will see how w…

This is the first study in people for a new drug called BL0175. It aims to find a safe dose and see if it can help control advanced breast, ovarian, or endometrial cancers that have stopped responding to standard hormone therapies in postmenopausal women. The study will closely m…

This study aims to see how well the drug T-DXd works in real-world settings for patients with advanced HER2-positive cancers who have already tried other treatments and have no good options left. It will follow about 100 patients with various solid tumors (excluding breast, lung,…

This study is testing a new drug called Rina-S in people whose solid tumor cancers have spread or cannot be removed by surgery. The main goals are to find a safe dose and see if the drug can shrink tumors. It is for people with several types of advanced cancer, including ovarian,…

This study is testing whether a new drug called ivonescimab can help control advanced endometrial or cervical cancer that has continued to grow despite previous treatment. The drug works by targeting two different pathways that cancer cells use to grow and evade the immune system…

This study is testing whether combining two drugs, avelumab and M1774, can help control a specific type of recurrent endometrial (uterine) cancer that has a mutation in the ARID1A gene. It is for patients whose cancer has come back after prior treatment, including immunotherapy. …

This study is testing if a pill called selinexor can help keep advanced or recurrent endometrial cancer from coming back after successful chemotherapy. It will involve 276 adults whose cancer responded well to initial treatment. Participants will be randomly assigned to take eith…

This study is testing a new drug called ubamatamab, given alone or with another drug (cemiplimab), for people with recurrent ovarian, fallopian tube, peritoneal, or endometrial cancers. The main goals are to find a safe and effective dose and to see if the treatment can shrink tu…

This large, late-stage trial is testing whether a new targeted drug called puxitatug samrotecan helps people with advanced endometrial cancer live longer or live longer without their cancer getting worse, compared to standard chemotherapy. It is for people whose cancer has contin…

This is an early-stage study to check the safety and initial activity of an experimental drug called DR-0202. It is for adults with advanced cancers that have spread, returned, or stopped responding to at least two prior treatments. The main goal is to find a safe dose and see ho…

This study is testing whether custom 3D-printed devices can improve a type of internal radiation therapy for gynecologic cancers. The goal is to see if these patient-specific devices are a feasible and potentially better alternative to the standard wax molds or cylinders currentl…

This study is testing whether a simple tampon sample can be used to find early signs of uterine or ovarian cancer. Researchers are enrolling 1,500 women who are already scheduled for surgery to remove their uterus or ovaries. They will compare DNA markers found in the tampon samp…

This study aims to develop a new test to detect endometrial, ovarian, and cervical cancers. Researchers are looking for chemical markers in vaginal fluid and blood samples from over 3,000 women. The goal is to create a less invasive way to find these cancers earlier, when they ar…

This study aims to find the best dose and storage method for a special green dye (Indocyanine Green) used during surgery for uterine, cervical, or vulvar cancer. The dye helps surgeons see and test the first lymph nodes where cancer might spread. Researchers will test different a…

This early study is testing whether a drug called CYTALUX, which makes cancer cells glow under a special camera, can help surgeons see endometrial cancer more clearly during surgery. The goal is to see if this helps find more cancer tissue that needs to be removed. About 10 patie…

This study is testing a new computer model called ENDORISK in real-world clinics. It helps doctors and patients with early-stage endometrial cancer better understand the risk of the cancer spreading to lymph nodes before surgery. The goal is to see if using this tool improves dec…

This study is testing whether a new, non-invasive test using a patient-collected urine sample or vaginal swab can accurately detect endometrial (uterine) cancer. The goal is to create a simpler, more comfortable alternative to current invasive diagnostic procedures. Researchers w…

This study is testing whether a menstrual cup used at home can collect good samples from the lining of the uterus to screen for cancer. It compares the cup samples to those taken during a standard, more invasive biopsy procedure. The goal is to find a gentler and more convenient …

This study is testing a new type of imaging scan to see if it can better detect and monitor many different solid tumors. The scan uses a special tracer that attaches to a protein called Trop2, which is often found on cancer cells. Researchers will compare this new scan to standar…

This study aims to see if a newer, faster molecular test (OSNA) works as well as the current standard method (ultrastaging) for detecting whether endometrial cancer has spread to nearby lymph nodes during surgery. Researchers will randomly assign nearly 2,000 patients to have the…

This study is testing whether women with Lynch syndrome can use simple home vaginal swabs to detect early signs of uterine cancer. Researchers want to see if these self-collected samples can find DNA changes that might indicate cancer risk. The study also checks if participants f…

This study is testing a new blood test designed to detect many types of cancer early, before symptoms appear. It will involve 7,000 people, both with and without cancer, to see if the test can accurately spot cancer signals and identify where in the body the cancer started. The t…

This study is testing a new diagnostic platform that uses artificial intelligence to analyze small pieces of a patient's tumor. The goal is to predict whether a patient's cancer will respond to immunotherapy drugs before they start treatment. Researchers will compare the AI's pre…

This study aims to create a web-based educational tool to help women and their healthcare providers make informed decisions about preventing endometrial (uterine) cancer. The tool will focus on the option of using a hormone-releasing intrauterine device (IUD) as a primary prevent…

This study aims to find the best time to send encouraging messages to help older cancer survivors be more physically active. Researchers will test if receiving a message makes participants more likely to be active in the next hour and if it affects their pain levels over the next…

This study is testing if using the Headspace mindfulness app can help women with endometrial or cervical cancer feel less stressed and have a better quality of life during their cancer treatment. Researchers want to see if practicing mindfulness with the app can also help reduce …

This study is testing whether a 16-week home exercise program, done over video calls, can help women with ovarian or endometrial cancer who are receiving chemotherapy after surgery. Researchers want to see if the exercise helps patients keep their leg strength and mobility, and r…

This study compares how well the cancer drug T-DXd works compared to standard treatments for patients with advanced HER2-positive solid tumors. Researchers will analyze existing medical records from about 105 patients who received either T-DXd in previous trials or standard care …

This study aims to collect detailed genetic information and health records from 25,000 adults who have cancer or are at risk of developing it. Researchers will analyze this data to better understand how cancer develops and to identify potential targets for future treatments. The …

This study collects tumor tissue samples from cancer patients to research whether laboratory tests can predict which patients will respond to immunotherapy drugs. Researchers will analyze how live tumor samples react to immunotherapy treatments in the lab, then compare those resu…

This study is testing a new artificial intelligence (AI) tool designed to help match people with advanced cancer to suitable clinical trials. It will enroll up to 50,000 patients to see if using this AI system makes it easier for patients to find and join trials. The researchers …

This study aims to see if endometrial cancer tissue samples, collected during a patient's standard surgery at other hospitals, can be successfully shipped and then grown into 3D 'organoids' (mini-tumors) in the lab. Researchers will enroll about 20 patients to check if the shippi…

This study aims to collect real-world information about patients with advanced endometrial cancer in Russia. Researchers will analyze tumor samples from 500 patients to understand specific genetic and molecular characteristics. The study will also document what first-line treatme…

This study aims to understand the long-term digestive and urinary side effects in women who received advanced radiation therapy after surgery for cervical or endometrial cancer. Researchers will review the medical records of 300 women treated between 2020 and 2023 to see how ofte…

This study aims to see if tracking changes in a common inflammation marker (CRP) in the blood can predict how well patients with advanced gynecologic cancers respond to immunotherapy. It will involve 120 women already scheduled to receive standard immunotherapy and chemotherapy. …

This study aims to understand women's perspectives and knowledge about endometrial (uterine) cancer risk and prevention options. Researchers will interview 45 women—some with cancer, some at risk, and some healthy—to learn about their attitudes. The goal is to create better educa…

This study aims to understand if giving chemotherapy before surgery improves the physical fitness and thinking skills of older adults with advanced ovarian or endometrial cancer. Researchers will observe 35 participants, measuring their frailty and cognitive function before and a…

This study is testing a special type of ultrasound imaging to see if it can detect early changes in vaginal tissue caused by a standard radiation treatment for endometrial cancer. The goal is to see if this imaging can predict which patients might develop side effects like vagina…

This study is building a large, long-term database of health information and biological samples from people with cancer, people at risk for cancer, and healthy volunteers. The goal is to collect this data to help researchers better understand what causes cancer and how to prevent…

This study aims to understand how often early-stage uterine cancer comes back after standard surgery that includes a sentinel lymph node biopsy. It will also track how often patients develop long-term leg swelling (lymphedema) as a side effect of this procedure. Researchers will …

This study is a national registry that will follow nearly 2,000 patients in Germany with advanced ovarian or endometrial cancer for up to three years. Its purpose is to document the real-world treatments patients receive, track how the disease progresses, and measure their qualit…

This study is investigating whether a standard surgical tool used to move the uterus during minimally invasive surgery for early-stage endometrial cancer might cause cancer cells to spill into the abdomen. Researchers will randomly assign patients to have surgery either with or w…

This study aims to collect tissue samples and health information from 1,120 people to better understand why some families get colorectal or endometrial cancer. Researchers will store these samples to study in the future, hoping to discover new genetic causes and potential targets…

This early-stage study aims to understand the safety and imaging properties of an experimental radioactive tracer called RAD301. The research involves 9 participants, including both healthy volunteers and people with specific cancers like pancreatic, lung, or ovarian cancer. Part…

This study aims to see if changes in what people buy—like pain relief or digestive aids—can serve as an early warning sign for certain cancers. Researchers will compare the shopping history of 1,450 recently diagnosed cancer patients with 1,450 people without cancer, using up to …

This study is testing whether short educational videos can help more women with ovarian or endometrial cancer get recommended genetic testing. Researchers will enroll 30 patients to watch a video and then check medical records to see if testing rates improve. The goal is to find …